Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
CC transcript
|
|
REGENERON PHARMACEUTICALS, INC. (REGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 08/03/2023 |
8-K
| Quarterly results |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
8-K
| Quarterly results |
| 01/09/2023 |
8-K
| Quarterly results |
| 12/20/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 10/03/2022 |
8-K
| Quarterly results |
| 08/03/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 06/02/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 03/08/2022 |
8-K
| Quarterly results |
| 02/04/2022 |
8-K
| Quarterly results |
| 01/10/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 11/04/2021 |
8-K
| Quarterly results |
| 09/16/2021 |
8-K
| Quarterly results |
| 08/05/2021 |
8-K
| Quarterly results |
| 06/16/2021 |
8-K
| Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
| 02/05/2021 |
8-K
| Quarterly results |
| 01/15/2021 |
8-K
| Quarterly results |
| 01/11/2021 |
8-K
| Quarterly results |
| 01/05/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/05/2020 |
8-K
| Quarterly results |
| 08/19/2020 |
8-K
| Quarterly results |
| 08/12/2020 |
8-K
| Quarterly results |
| 08/05/2020 |
8-K
| Quarterly results |
| 07/07/2020 |
8-K
| Quarterly results |
| 06/16/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/29/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"Execution Version REGENERON PHARMACEUTICALS, INC. 11,831,496 Shares of Common Stock UNDERWRITING AGREEMENT",
"[Letterhead of Wachtell, Lipton, Rosen & Katz]",
"REPURCHASE",
"Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591",
"EXECUTION VERSION CREDIT AGREEMENT" |
|
| 05/05/2020 |
8-K
| Quarterly results |
|
|
|